The Effects of Synbiotic Supplementation on Glycemic Status, Lipid Profile, and Biomarkers of Oxidative Stress in Type 1 Diabetic Patients. A Placebo-Controlled, Double-Blind, Randomized Clinical Trial

Ahmad Zare Javid,1,2 Majid Aminzadeh,3 Mohammad Hosein Haghighi-zadeh,4 Mona Jamalvandi2,5 1Nutrition and Metabolic Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran; 2Department of Nutrition, School of Allied Medical Sciences, Ahvaz Jundishapur University of Me...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Zare Javid A, Aminzadeh M, Haghighi-zadeh MH, Jamalvandi M
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2020
Materias:
Acceso en línea:https://doaj.org/article/6ac1c7c9cc594f54bcd8520da7f77f3e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6ac1c7c9cc594f54bcd8520da7f77f3e
record_format dspace
spelling oai:doaj.org-article:6ac1c7c9cc594f54bcd8520da7f77f3e2021-12-02T07:19:35ZThe Effects of Synbiotic Supplementation on Glycemic Status, Lipid Profile, and Biomarkers of Oxidative Stress in Type 1 Diabetic Patients. A Placebo-Controlled, Double-Blind, Randomized Clinical Trial1178-7007https://doaj.org/article/6ac1c7c9cc594f54bcd8520da7f77f3e2020-03-01T00:00:00Zhttps://www.dovepress.com/the-effects-of-synbiotic-supplementation-on-glycemic-status-lipid-prof-peer-reviewed-article-DMSOhttps://doaj.org/toc/1178-7007Ahmad Zare Javid,1,2 Majid Aminzadeh,3 Mohammad Hosein Haghighi-zadeh,4 Mona Jamalvandi2,5 1Nutrition and Metabolic Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran; 2Department of Nutrition, School of Allied Medical Sciences, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran; 3Pediatric Endoscopy and Metabolism, Diabetes Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran; 4Department of Biostatistics, School of Public Health, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran; 5Student Research Committee, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IranCorrespondence: Mona JamalvandiDepartment of Nutrition, School of Allied Medical Sciences, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IranTel +98 9185877499Email m.jamalvandi71@yahoo.comBackground and Objective: The aim of the present study was to evaluate the effects of synbiotic on glycemic status, lipid profile, and biomarkers of oxidative stress in type 1 diabetes mellitus (T1DM) patients.Materials and Methods: In this double-blind clinical trial, 50 T1DM patients were randomly allocated to intervention (n = 25) and control (n = 25) groups and received either synbiotic powder (Lactobacillus sporogenes GBI-30 (probiotic), maltodextrin and fructooligosaccharide (prebiotic)) or placebo 2 g per day for 8 weeks. Fasting blood samples were collected before and after the intervention to measure fasting blood glucose (FBG), insulin concentration, hemoglobin A1c (HbA1c), lipid profile, and biomarkers of oxidative stress such as total antioxidant capacity (TAC) and hs-C-reactive protein (hs-CRP).Results: Supplementation with synbiotic resulted in a significant decrease in the mean serum levels of HbA1c and hs-CRP (p = 0.01 and p = 0.004, respectively), and marginally significant decrease in FBG (p = 0.05) in the intervention group post- intervention. Also, the mean changes of FBG and hs-CRP were significantly lower in the intervention group compared with the control group (p = 0.03 and p = 0.005, respectively). There were no significant changes found in lipid profile in intervention group post-intervention (p≥ 0.05). The mean serum levels of insulin and TAC were significantly increased in the intervention group post-intervention (p = 0.001). There was a significant increase in the mean changes of TAC (p = 0.005) in the intervention group compared with the control group.Conclusion: The 8-week synbiotic supplementation in T1DM patients may be effective in improvement of FBG, HbA1c, insulin, hs-CRP, and TAC.Keywords: type 1 diabetes mellitus, synbiotic, glycemic status, lipid profile, inflammationZare Javid AAminzadeh MHaghighi-zadeh MHJamalvandi MDove Medical Pressarticletype 1 diabetes mellitussynbioticglycemic statuslipid profileinflammationSpecialties of internal medicineRC581-951ENDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol Volume 13, Pp 607-617 (2020)
institution DOAJ
collection DOAJ
language EN
topic type 1 diabetes mellitus
synbiotic
glycemic status
lipid profile
inflammation
Specialties of internal medicine
RC581-951
spellingShingle type 1 diabetes mellitus
synbiotic
glycemic status
lipid profile
inflammation
Specialties of internal medicine
RC581-951
Zare Javid A
Aminzadeh M
Haghighi-zadeh MH
Jamalvandi M
The Effects of Synbiotic Supplementation on Glycemic Status, Lipid Profile, and Biomarkers of Oxidative Stress in Type 1 Diabetic Patients. A Placebo-Controlled, Double-Blind, Randomized Clinical Trial
description Ahmad Zare Javid,1,2 Majid Aminzadeh,3 Mohammad Hosein Haghighi-zadeh,4 Mona Jamalvandi2,5 1Nutrition and Metabolic Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran; 2Department of Nutrition, School of Allied Medical Sciences, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran; 3Pediatric Endoscopy and Metabolism, Diabetes Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran; 4Department of Biostatistics, School of Public Health, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran; 5Student Research Committee, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IranCorrespondence: Mona JamalvandiDepartment of Nutrition, School of Allied Medical Sciences, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IranTel +98 9185877499Email m.jamalvandi71@yahoo.comBackground and Objective: The aim of the present study was to evaluate the effects of synbiotic on glycemic status, lipid profile, and biomarkers of oxidative stress in type 1 diabetes mellitus (T1DM) patients.Materials and Methods: In this double-blind clinical trial, 50 T1DM patients were randomly allocated to intervention (n = 25) and control (n = 25) groups and received either synbiotic powder (Lactobacillus sporogenes GBI-30 (probiotic), maltodextrin and fructooligosaccharide (prebiotic)) or placebo 2 g per day for 8 weeks. Fasting blood samples were collected before and after the intervention to measure fasting blood glucose (FBG), insulin concentration, hemoglobin A1c (HbA1c), lipid profile, and biomarkers of oxidative stress such as total antioxidant capacity (TAC) and hs-C-reactive protein (hs-CRP).Results: Supplementation with synbiotic resulted in a significant decrease in the mean serum levels of HbA1c and hs-CRP (p = 0.01 and p = 0.004, respectively), and marginally significant decrease in FBG (p = 0.05) in the intervention group post- intervention. Also, the mean changes of FBG and hs-CRP were significantly lower in the intervention group compared with the control group (p = 0.03 and p = 0.005, respectively). There were no significant changes found in lipid profile in intervention group post-intervention (p≥ 0.05). The mean serum levels of insulin and TAC were significantly increased in the intervention group post-intervention (p = 0.001). There was a significant increase in the mean changes of TAC (p = 0.005) in the intervention group compared with the control group.Conclusion: The 8-week synbiotic supplementation in T1DM patients may be effective in improvement of FBG, HbA1c, insulin, hs-CRP, and TAC.Keywords: type 1 diabetes mellitus, synbiotic, glycemic status, lipid profile, inflammation
format article
author Zare Javid A
Aminzadeh M
Haghighi-zadeh MH
Jamalvandi M
author_facet Zare Javid A
Aminzadeh M
Haghighi-zadeh MH
Jamalvandi M
author_sort Zare Javid A
title The Effects of Synbiotic Supplementation on Glycemic Status, Lipid Profile, and Biomarkers of Oxidative Stress in Type 1 Diabetic Patients. A Placebo-Controlled, Double-Blind, Randomized Clinical Trial
title_short The Effects of Synbiotic Supplementation on Glycemic Status, Lipid Profile, and Biomarkers of Oxidative Stress in Type 1 Diabetic Patients. A Placebo-Controlled, Double-Blind, Randomized Clinical Trial
title_full The Effects of Synbiotic Supplementation on Glycemic Status, Lipid Profile, and Biomarkers of Oxidative Stress in Type 1 Diabetic Patients. A Placebo-Controlled, Double-Blind, Randomized Clinical Trial
title_fullStr The Effects of Synbiotic Supplementation on Glycemic Status, Lipid Profile, and Biomarkers of Oxidative Stress in Type 1 Diabetic Patients. A Placebo-Controlled, Double-Blind, Randomized Clinical Trial
title_full_unstemmed The Effects of Synbiotic Supplementation on Glycemic Status, Lipid Profile, and Biomarkers of Oxidative Stress in Type 1 Diabetic Patients. A Placebo-Controlled, Double-Blind, Randomized Clinical Trial
title_sort effects of synbiotic supplementation on glycemic status, lipid profile, and biomarkers of oxidative stress in type 1 diabetic patients. a placebo-controlled, double-blind, randomized clinical trial
publisher Dove Medical Press
publishDate 2020
url https://doaj.org/article/6ac1c7c9cc594f54bcd8520da7f77f3e
work_keys_str_mv AT zarejavida theeffectsofsynbioticsupplementationonglycemicstatuslipidprofileandbiomarkersofoxidativestressintype1diabeticpatientsaplacebocontrolleddoubleblindrandomizedclinicaltrial
AT aminzadehm theeffectsofsynbioticsupplementationonglycemicstatuslipidprofileandbiomarkersofoxidativestressintype1diabeticpatientsaplacebocontrolleddoubleblindrandomizedclinicaltrial
AT haghighizadehmh theeffectsofsynbioticsupplementationonglycemicstatuslipidprofileandbiomarkersofoxidativestressintype1diabeticpatientsaplacebocontrolleddoubleblindrandomizedclinicaltrial
AT jamalvandim theeffectsofsynbioticsupplementationonglycemicstatuslipidprofileandbiomarkersofoxidativestressintype1diabeticpatientsaplacebocontrolleddoubleblindrandomizedclinicaltrial
AT zarejavida effectsofsynbioticsupplementationonglycemicstatuslipidprofileandbiomarkersofoxidativestressintype1diabeticpatientsaplacebocontrolleddoubleblindrandomizedclinicaltrial
AT aminzadehm effectsofsynbioticsupplementationonglycemicstatuslipidprofileandbiomarkersofoxidativestressintype1diabeticpatientsaplacebocontrolleddoubleblindrandomizedclinicaltrial
AT haghighizadehmh effectsofsynbioticsupplementationonglycemicstatuslipidprofileandbiomarkersofoxidativestressintype1diabeticpatientsaplacebocontrolleddoubleblindrandomizedclinicaltrial
AT jamalvandim effectsofsynbioticsupplementationonglycemicstatuslipidprofileandbiomarkersofoxidativestressintype1diabeticpatientsaplacebocontrolleddoubleblindrandomizedclinicaltrial
_version_ 1718399460064624640